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Edited by Jesus AvilaAbstract PrPc (cellular prion protein) and Doppel are antago-
nizing proteins, respectively neuroprotective and neurotoxic.
Evidence for Doppel neurotoxicity came from PrPc-deﬁcient
(Prnp0/0) mouse lines developing late onset Purkinje-cell degen-
eration caused by Doppel overexpression in brain. To address
the molecular underpinnings of this cell-type speciﬁcity, we gen-
erated Doppel N-terminal-speciﬁc antibodies and started to
examine the spatio-temporal expression of Doppel protein spe-
cies in Ngsk Prnp0/0 brain. Although Doppel overexpression is
ubiquitous, Western analyses of normal and deglycosylated pro-
tein extracts revealed cerebellar patterns distinct from the rest of
the brain, supporting the idea that neurotoxicity might be linked
to a particular Doppel species pattern. Furthermore, our newly
raised antibodies allowed the ﬁrst Doppel immunohistochemical
analyses in brain, showing a distribution in Prnp0/0 cerebellum
similar to PrPc in wild type.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The physiological function of cellular prion protein (PrPc)
remains elusive, although its requirement for prion disease
propagation is established [1,2]. Hence, PrPc-deﬁcient (Prnp0/0)
mice were generated, surprisingly leading to two phenotypes:
Zrch I and Edbg lines [3,4] showed only minor defects [3–5],
whereas Ngsk, Rcm0 and Zrch II lines showed Purkinje-cell
(PC) degeneration causing cerebellar ataxia in aging animals
[6–8]. Later, this neurodegenerative disease was linked to the
overexpression of the newly discovered mouse Doppel protein
gene (Prnd), located 16 kb downstream of mouse prion protein
gene (Prnp) and which encodes a PrPc homologue termedAbbreviations: Dpl, Doppel protein; PrPc, cellular prion protein; Prnd,
mouse Doppel protein gene; Prnp, mouse prion protein gene; Prn,
mouse Prnp and Prnd locus; PC, Purkinje cell; mAb, monoclonal an-
tibody; pAb, polyclonal antibody; PNGase F, peptide-N-glycosidase
F; LDS, lithium dodecyl sulfate; MES, 2-(N-morpholino)ethanesul-
fonic acid
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doi:10.1016/j.febslet.2005.04.007Doppel (Dpl) [7]. Dpl and PrPc are both glycosylphosphat-
idylinositol (GPI)-anchored proteins containing two N-linked
oligosaccharides and intramolecular disulﬁde bonds; in com-
parison with PrPc, Dpl lacks the N-terminal octamer repeat,
but displays 25% identity with the C-terminal sequence and
similar folding [9,10]. Although the precise function of Dpl re-
mains unclear [11,12], it appeared that Dpl and PrPc are antag-
onistic, respectively neurotoxic and neuroprotective. Indeed,
introducing a wild-type Prnp gene into disease-developing
Prnp0/0 mice abolished the ataxic phenotype [8,13–15].
In wild-type mice, as well as in healthy phenotype Prnp0/0
lines, Prnd is expressed at high levels in testis and at very
low levels in brain. In contrast, in ataxic phenotype Prnp0/0
lines (Ngsk, Rcm0 and Zrch II), Prnd was shown to be overex-
pressed in brain [7,8,16], an upregulation which occurs under
the control of the Prnp promoter and is associated with an
intergenic splicing event generating chimeric Prnp/Prnd tran-
scripts [7,17]. The role of Dpl in PC death and ataxia is further
convincingly supported by results showing that ataxia is trig-
gered oﬀ earlier by increasing Dpl levels [8,18], that this disor-
der is prevented in mice lacking the Prnp/Prnd locus (Prn0/0)
[19] and that Dpl appeared to be neurotoxic in cell-culture
models [20].
Intriguingly, Dpl toxicity speciﬁcally aﬀects Purkinje neu-
rons, only at an advanced age, whereas Dpl is ubiquitously
overexpressed in Prnp0/0 brain during the entire lifespan [8,9]
(our present data) of the mice. As a starting point to investigate
the totally unknown mechanisms underlying this cell-type spec-
iﬁcity, we elected to focus on the spatio-temporal expression of
Dpl protein species. Indeed, as Western analyses of total brain
revealed a complex 27–35-kDa heterodisperse band comprised
of numerous glycosylated protein species [7,8,13], the question
was whether the expression of the diﬀerent molecular species is
spatio-temporally regulated in brain. Herein, we address this
issue by separately investigating the cerebellum and the rest
of the brain of Prnp0/0 10-week-old (healthy) and 72-week-old
(ataxic) Ngsk mice. Therefore, we generated and immunopuri-
ﬁed new anti-Dpl antibodies, which were also used for in situ
localization in these cerebral tissues.2. Materials and methods
2.1. Mouse lines and tissues
All animals were used in accordance with the Institut National de la
Sante´ et de la Recherche Me´dicale guidelines for care and use of lab-
oratory animals. Wild-type and Ngsk Prnp0/0 mice [6] used in thisblished by Elsevier B.V. All rights reserved.
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genotype was determined by PCR. Prnp0/0 (Zrch I) [3], Prnd0/0 [12]
and Prn0/0 [19] cerebral tissues were used as controls.
2.2. Polyclonal antibodies
Anti-Dpl antibodies were raised by immunizing rabbits with mouse
Dpl synthetic peptide GIKHRFKWNRKVLPSSGGQITEAR-
VAENRPGAFIKQGRK (MoDpl 28–66; Swissprot Accession No.:
Q9QUG3) conjugated to ovalbumin. Antibodies were puriﬁed on Sulf-
olink immunoaﬃnity matrix (Pierce) coupled to peptide, according to
the manufacturer; antibodies are referred to as pAb44-Dpl\ and
pAb45-Dpl\. Crossreacting speciﬁcities were further removed by
adsorption on peptide PGAFIKQGRK (MoDpl 57–66); double
immunopuriﬁed antibodies are referred to as pAb44-Dpl and pAb45-
Dpl. Rabbit anti-PrP antibody was raised against mouse PrP synthetic
peptide KKRPKPGGWNTGGSRYPGQGS (PrP 23–43; Swissprot
Accession No.: P04925) and immunopuriﬁed on the same peptide;
the antibody is termed pAb11-PrP.
2.3. Tissular extracts
Brain and testis were homogenized (20% w/v) either in cold PBS con-
taining 1% Triton X-100 or lithium dodecyl sulfate (LDS) denaturing
solution containing 172 mM Tris–HCl, pH 8.0, 5.2% LDS, 40 mM
dithiothreitol, 10% glycerol [21], and one protease inhibitor cocktail
tablet per 10 ml (Complete Mini EDTA-free, Roche). Extracts were
sonicated, centrifuged at 10000 · g for 10 min. LDS extracts were
heated at 95 C for 5 min. All extracts were stored at 80 C.
2.4. Deglycosylation
Brain and testis extracts in PBS, 1% Triton X-100 were precipitated
overnight at 20 C with 5 volumes of methanol and centrifuged for
10 min at 10000 · g. For N-deglycosylation, pellets were resuspendedFig. 1. Speciﬁcity of anti-Dpl and anti-PrP antibodies. Antibodies were chara
and wild-type counterparts (Prnp+/+), from Zrch I Prnp0/0, Prnd0/0 and Prn0/0
were prepared in LDS denaturing buﬀer and resolved on 12% SDS–polyacryl
30 lg/lane); BL21 MoDpl (BL21 MoDpl bacteria; 0.1 lg/lane; I: IPTG
immunopuriﬁed antibody pAb45-Dpl\ (panel a), double-immunopuriﬁed
immunopuriﬁed antibody pAb11-PrP (panel d). Loadings were controlled usin
arrowhead to the recombinant MoDpl monomer. Molecular masses are indat 8 mg of protein per ml of denaturing buﬀer (0.5% SDS, 1% b-
mercaptoethanol), heated at 95 C for 5 min and kept on ice for
5 min. After adding 1/10 volume of each 0.5 M sodium phosphate,
pH 7.5, and 10% NP-40, samples were treated with 0.1 IU of pep-
tide-N-glycosidase F (PNGase F, New England BioLabs) per mg of
protein for 90 min at 37 C. Alternatively, N-deglycosylation and
N- plus O-deglycosylation were performed with the E-DEGLY kit
(Sigma), using PNGase F or a mixture containing PNGase F, O-glyco-
sidase, a-2(3,6,8,9)-neuraminidase, b(1–4)-galactosidase and b-N-acet-
ylglucosaminidase; treatments were for 3 h at 37 C. Reaction
conditions (enzyme concentrations and incubation periods) were ad-
justed so as to ensure complete deglycosylation. Reactions were
stopped by adding one volume of 2· LDS denaturation buﬀer and
samples heated at 95 C for 5 min.2.5. Recombinant Doppel protein
The mouse Prnd ORF [7] was ampliﬁed by PCR from C57BL/6J
mouse DNA using the following primers: sense 5 0-CATATGAA-
GAACCGGCTGGGTACATGGT-3 0 (NdeI site underlined) and anti-
sense 5 0-CTCGAGCTTCACAATGAACCAAACGAAA-3 0 (XhoI site
underlined). The NdeI–XhoI cDNA fragment was subcloned into vec-
tor pET-31b (Novagen), thus encoding C-terminal 6xHis-tagged full
length Dpl (theoretical MW: 21.3 kDa). Transformed Escherichia coli
BL21 bacteria were induced with 1 mM IPTG or not at 37 C for
3.5 h. After centrifugation, pellets were resuspended in LDS denatur-
ing buﬀer, heated at 95 C for 5 min and samples stored at 20 C.2.6. Western analysis
Proteins in LDS denaturing buﬀer were resolved on a modiﬁed 12%
SDS–polyacrylamide gel system, with a running gel buﬀer containing
0.6 M Tris, 130 mM 2-(N-morpholino)ethanesulfonic acid (MES),cterized by Western analysis. Tissular extracts from Ngsk Prnp0/0 mice
mice, and also extracts from recombinant E. coli BL21-MoDpl bacteria
amide gels in Tris/MES–urea: brain (B; 50 lg of protein/lane); testis (T;
induced; NI: non-induced). Immunodetection was with single-
antibodies pAb45-Dpl (panel b) and pAb44-Dpl (panel c), and
g mAb-b actin antibody. The arrow points to the 27-kDa band and the
icated in kilodaltons.
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electrotransferred onto PVDF sheets and blots incubated for 1 h in
blocking solution (PBS, 0.5% casein, and 0.2% Tween 20) and over-
night at 4 C with pAb44-Dpl (1 lg/ml), pAb45-Dpl (1 lg/ml),
pAb11-PrP (0.1 lg/ml) or a mouse monoclonal anti-b actin antibody
(1:400000) (AC-15, Sigma) in 0.1· blocking solution. After washing
with PBS, 0.05% Tween 20, blots were incubated with peroxidase-con-
jugated F(ab 0)2 donkey anti-rabbit or anti-mouse IgG (Jackson Immu-
noResearch) in 0.1· blocking solution (1:400000). Blots were
developed using the SuperSignal West Femto chemiluminescence kit
(Pierce).2.7. Immunohistochemistry
Dissected brains were rapidly frozen in isopentane kept on dry ice,
and stored at 80 C. 10-lm thick frozen sections were collected on
Superfrost Plus glass slides (Esco), ﬁxed for 4 min with 4% parafor-
maldehyde in PBS, rinsed with PBS and incubated for 2 · 5 min in
PBS, 0.1% Triton X-100 (PBS–TX). Sections were incubated for 1 h
in blocking solution (PBS–TX, 10% heat-inactivated normal goat ser-
um) and for 16 h at 4 C in the same solution containing pAb44-Dpl
(2 lg/ml) or pAb11-PrP (1 lg/ml). After washing with PBS–TX, sec-
tions were incubated for 90 min in Cy3-conjugated F(ab 0)2 donkey
anti-rabbit IgG (Jackson ImmunoResearch) diluted 1:200 in blocking
solution, rinsed with PBS–TX, equilibrated with PBS and counter-
stained with Hoechst 33258 dye. Preparations were mounted in
glycerol/PBS (4:1), 5% propylgallate and examined with a photomi-
croscope (Leitz DMR, Leica) equipped with an Axiocam camera
(Zeiss).Fig. 2. Western analysis of Dpl molecular species patterns in Ngsk
Prnp0/0 mouse tissues and wild-type counterparts using antibody
pAb45-Dpl. Tissues were from 10- and 72-week-old mice: brain (B),
cerebellum (C), brain minus cerebellum (B\) and testis (T). Tissular
extracts prepared in LDS denaturing buﬀer were separated on 12%
SDS–polyacrylamide gels in Tris/MES–urea (cerebral tissue: 50 lg of
protein/lane; testis: 30 lg/lane); control BL21 MoDpl (I, induced)
extract (0.1 lg/lane). Immunodetection was with antibody pAb45-Dpl;
for loading controls, blots were probed with mAb-b actin antibody.
Molecular masses are indicated in kilodaltons.3. Results and discussion
To investigate whether the expression of Dpl protein spe-
cies is spatio-temporally regulated in brain, a prerequisite
was to improve the resolution of the heterogeneous or heter-
odisperse 27–35-kDa signal observed in previous Western
analyses [7,9,22,23]. Using a modiﬁed gel-electrophoresis pro-
cedure in which proteins are solubilized in LDS denaturing
buﬀer and separated on a 12% SDS–polyacrylamide gel in
Tris/MES–urea buﬀer [21], allowed a resolution suﬃcient to
distinguish individual Dpl bands within the 27–35-kDa
range.
In contrast to anti-PrP antibodies, anti-Dpl antibodies pro-
duced to date apparently do not exhibit high enough speciﬁcity
and/or aﬃnity, thus hindering further advances in Dpl studies.
A case in point is the failure to localize Dpl in situ within brain
overexpressing the protein. In this context, we raised new rab-
bit anti-Dpl polyclonal antibodies (pAbs), focusing our atten-
tion on pAb44-Dpl\ and pAb45-Dpl\ directed against MoDpl
peptide 28–66 and which were immunopuriﬁed on the same
peptide. Antibody pAb45-Dpl\ speciﬁcally recognizes recom-
binant monomeric and multimeric MoDpl in bacterial extracts
(Fig. 1a, lane 5), and in Ngsk Prnp0/0 brain, as well as in testis,
reveals several bands within the 27–35-kDa range (lanes 3 and
4). Similar patterns are observed with pAb44-Dpl\ (not
shown). However, these antibodies exhibit crossreactivities in
mouse tissues since the 27-kDa band (Fig. 1a, arrow), also ob-
served in wild-type (lane 2), is detected in Prnd0/0 brain (lane
1). Aiming at the removal of crossreactivities, antibodies were
competed in Western assays with each of a series of overlap-
ping Dpl synthetic peptides, which allowed to localize the
crossreacting epitope in the C-terminal end (57PGA-
FIKQGRK66) of MoDpl 28–66 peptide. After adsorption on
peptide PGAFIKQGRK, the antibodies, then referred to as
pAb44-Dpl and pAb45-Dpl, no longer detected the 27-kDaband in any of the analyzed tissues. This includes wild-type
and Ngsk Prnp0/0 brain and testis (Fig. 1b and c, lanes 1, 2
and 7; Prnp0/0 testis not shown), Prnd0/0 and Prn0/0 brain and
testis controls (Fig. 1b and c, lanes 3, 4 and 6) as well as ZrchI
Prnp0/0 brain (Fig. 1b and c, lane 5). These highly speciﬁc dou-
ble immunopuriﬁed antibodies were then used for comparative
Western analyses within brain. For PrPc detection, we used
pAb11-PrP, the N-terminal PrP 23–43 speciﬁc antibody we
produced, immunopuriﬁed and further characterized (Fig. 1d).
Since preliminary Western analysis of diﬀerent cerebral areas
revealed that Dpl protein is ubiquitously overexpressed in
Ngsk Prnp0/0 brain (data not shown), it became obvious that
Dpl toxicity, which exclusively aﬀects the aged cerebellum,
cannot just be ascribed to overexpression. Therefore, we fo-
cused our investigations on the cerebellum of Ngsk Prnp0/0
mice, ﬁrst analyzing the Dpl protein pattern by Western blot-
ting in comparison with the rest of the brain. Using antibody
pAb45-Dpl, we show that in healthy Prnp0/0 10-week-old mice
as well as in ataxic 72-week-old mice the cerebellar pattern
(Fig. 2, lanes 6 and 13) indeed diﬀers from that of the rest of
the brain (lanes 7 and 14); total Prnp0/0 brain shows the ex-
pected pattern (lanes 5 and 12) and wild-type controls are neg-
ative (lanes 1–3 and 8–10). Of note, Dpl levels in the
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even lower than in the rest of the brain (lanes 6, 7, 13 and 14).
However, no signiﬁcant changes are observed in 72-week-old
mice (ataxic) (lanes 13 and 14) when compared with 10-
week-old mice (healthy) (lanes 6 and 7). Analysis of the cere-
bellum and the rest of the brain by two-dimensional Western
blotting conﬁrmed that Dpl patterns are distinct, pI values
ranging from 3 to 5, and further showed that the bulk of the
signal is actually slightly shifted to the less acidic values in
the ataxic cerebellum (data not shown). Given that the hetero-
disperse Dpl pattern is linked to glycosylations [7,9,22,23], dif-
ferential glycosylation is the most likely hypothesis to explain
the speciﬁcity of the cerebellar Dpl pattern. Moreover, this
would fall into line with recent genetic mapping studies which
led to the conclusion that Dpl proapoptotic activity might be
dependent upon an unknown biochemical property of the cen-
tral part of the molecule (Dpl 91–125 and Dpl 101–125), a re-
gion whose landmark feature is the presence of the N-linked
glycosylation sites [24].
In order to assess to what extent pattern diﬀerences corre-
late with diﬀerential glycosylation, proteins were analyzed fol-
lowing deglycosylation. Subsequent to N-deglycosylation
(Fig. 3a), testis control showed a major band at 15.5 kDa (ar-
row) which is the size of unmodiﬁed mature Dpl, and a minor
one at 20 kDa suggesting the presence of extra modiﬁcations
insensitive to PNGase F (lanes 1 and 2) and further showing
that Dpl in testis is essentially N-glycosylated. In contrast,
cerebral tissues from both Prnp0/0 10-week- (lanes 4, 6 and
8) and 72-week-old mice (lanes 10, 12 and 14) revealed more
complex patterns wherein unglycosylated Dpl is no more theFig. 3. Western analysis of deglycosylated Dpl molecular species patterns
cerebellum (C), brain minus cerebellum (B\) and testis (T) extract from 10
analyzed as in Fig. 2. Immunodetection was with antibody pAb45-Dpl; for lo
Extracts treated with PNGase F (+) or mock-treated (). Panel b: Extracts tre
enzymes. Arrowheads point to diﬀerent deglycosylation forms of Dpl. The
indicated in kilodaltons.major Dpl form, which is indicative of a greater occurrence of
PNGase F insensitive post-translational modiﬁcations. Inter-
estingly, the cerebellum still exhibits a Dpl pattern distinct
from that of the rest of the brain in both young (lanes 6
and 8) and aged Prnp0/0 mice (lanes 12 and 14), suggesting
that N-glycosylations are not the only possible post-transla-
tional modiﬁcations generating these diﬀerences. No obvious
pattern variations could be detected with aging. We then com-
bined N- and O-deglycosylations, which needs a longer incu-
bation time for reaction completion and therefore results in
weaker signals, probably due to some protein loss (Fig. 3b).
In these conditions, N-deglycosylation controls in young
Prnp0/0 mice are essentially unchanged (lanes 2 and 5; com-
pare with panel 3a), the mature unglycosylated form being
however too weak to be seen on the ﬁgure. Following com-
bined N- and O-deglycosylation of cerebellar proteins, the
20-kDa band is no longer detected, whereas the two lower
molecular weight bands are increased, the unmodiﬁed mature
Dpl being still undetectable (lane 3). A shift was also observed
in the rest of the brain (lane 6), but the pattern, in terms of
relative band intensities, still remains diﬀerent from that in
cerebellum. No pattern variations could be observed with
aging (not shown). Since these deglycosylation assays did
not lead to a unique band of unmodiﬁed mature Dpl
(15.5 kDa), our results suggest that the speciﬁcity as well
as the complexity characterizing the cerebellar Dpl protein
patterns are not only due to N- and O-glycosylations, but
that additional post-transcriptional modiﬁcations, insensitive
to deglycosylation and yet to be characterized, might also
be involved.in Ngsk Prnp0/0 mouse tissues using antibody pAb45-Dpl. Brain (B),
- and 72-week-old Ngsk Prnp0/0 mice were deglycosylated or not and
ading controls, blots were probed with mAb-b actin antibody. Panel a:
ated (+) or mock-treated () with both PNGase and O-deglycosylation
arrow points to the unmodiﬁed mature Dpl. Molecular masses are
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toxic properties of Dpl, beyond the necessary Dpl overexpres-
sion, might in fact be associated with a particular Dpl pattern
or even to one or several particular Dpl molecular species spe-
ciﬁcally expressed in young and/or aged Prnp0/0 cerebellum;
such speciﬁc Dpl species might possibly intervene in the regu-
lation of the oxidative stress previously shown to be correlated
with Dpl overexpression [20,25]. Regarding the delayed diseaseFig. 4. Immunohistochemistry of Dpl and PrPc proteins in the cerebellum of
Dpl and pAb11-PrP. Analyses were performed using frozen cerebellum sectio
counterparts (Prnp+/+). Lower panel: additional Prnd0/0 controls. Left column
Hoechst counterstain (blue). Right column: PrPc signal (Cy3 ﬂuorochrome) wi
signals were 10 times longer than for PrPc signals. GL: granular layer; ML:onset, it can also be hypothesized that other age-related molec-
ular events might potentiate the neurotoxicity of the cerebel-
lum-speciﬁc Dpl species.
Having such double immunopuriﬁed anti-Dpl antibodies
with signiﬁcantly improved speciﬁcity prompted us to assay
them on cerebellum frozen sections so as to compare the
distribution of Dpl in Ngsk Prnp0/0 cerebellum with that of
its PrPc antagonist in the wild-type counterpart (Fig. 4).Ngsk Prnp0/0 mice and wild-type counterparts using antibodies pAb44-
ns. Upper panel: 10- and 72-week-old Ngsk Prnp0/0 mice and wild-type
: Dpl localization (Cy3 ﬂuorochrome: red) with superimposed nuclear
th superimposed nuclear Hoechst counterstain. Exposure times for Dpl
molecular layer; WM: white matter.
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antibody pAb44-Dpl. In both Ngsk 10- and 72-weeks Prnp0/0
cerebellum, Dpl signal is essentially localized in the white
matter; here one may for instance speculate on Dpl species,
speciﬁcally associated with PC axons, triggering the degener-
ation of these cells. Of note, no signal is detected in the wild-
type (Prnp+/+) counterparts (internal negative controls) (Fig.
4, upper panel); a further negative control on Prnd0/0 cerebel-
lum does not show any signal either (lower panel), thus pro-
viding additional evidence for the speciﬁcity of antibody
pAb44-Dpl. Analysis of the same tissues using antibody
pAb11-PrP showed that PrPc is ubiquitously expressed in
10- and 72-weeks wild-type (Prnp+/+) cerebellum, the stron-
gest signal being detected in the white matter. This signal is
deﬁnitely speciﬁc as the control Prnp0/0 counterparts are to-
tally negative (Fig. 4, upper panel). Prnd0/0 cerebellum (lower
panel), as expected, displayed the same signal as wild-type
(Prnp+/+) cerebellum. Moreover, when using other antibodies
directed against diﬀerent regions of the PrP protein, namely
monoclonal antibodies (mAbs) SAF32 (anti-hamster PrP
79–92) and 6H4 (anti-human PrP 144–152), we obtained ex-
actly the same ubiquitously distributed PrPc signal, with the
most intense label in the white matter, Prnp0/0 controls being
totally negative too (not shown). Recently, previous immuno-
histochemical studies, including the proper Prnp0/0 negative
controls, clearly evidenced the presence of PrPc in the cerebel-
lar white matter [26,27], which was further conﬁrmed in trans-
genic mice expressing GFP-tagged PrP, an alternative
approach designed to obviate potential diﬃculties linked to
immunohistochemical protocols and individual anti-PrP anti-
bodies [28]. Thus, the fact that Dpl and PrPc are both found
in the cerebellar white matter is of great interest since Dpl and
PrPc are functionally antagonistic, PrPc counteracting Dpl
neurotoxicity [8,13–15,20]. Of note, Dpl signals are relatively
weak compared with PrPc, which can be at least in part as-
signed to much lower levels of Dpl in Ngsk Prnp0/0 brain,
as also evidenced by Western analysis (Fig. 1c, lane 2 and
d, lane 1). Finally, it is to be emphasized that the mild tissue
processing procedure we worked out – designed to best pre-
serve epitope integrity while preventing antigen loss – is cru-
cial in the speciﬁc detection of Dpl and further of the
strong ubiquitous PrPc signal in cerebellum.
In conclusion, owing to our new double immunopuriﬁed
anti-Dpl antibodies and a more resolutive Western blotting
system, we showed that the expression of Dpl protein species
is spatially and possibly also temporally regulated in Ngsk
Prnp0/0 brain. Indeed, within Prnp0/0 brain, cerebellum exhibits
a speciﬁc pattern of Dpl protein, suggesting that Dpl neurotox-
icity which exclusively targets PC might be linked to a partic-
ular Dpl pattern or to particular Dpl protein species among
the total population. Moreover, even if assumed that diﬀeren-
tial glycosylation plays a central role in generating this cerebel-
lum speciﬁc pattern, our data indicate that additional not yet
deﬁned post-translational modiﬁcations might also intervene.
Finally, these results open new perspectives to unravel the
physiological and pathophysiological functions of Dpl protein
and its relations with PrPc, all the more so since antibodies
with improved speciﬁcity, also working in situ on cerebral tis-
sues, are now available. This might also apply to human prion
diseases as well as to other neurodegenerative disorders, like
Alzheimers disease in which Dpl has been suggested to be in-
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